author-photo

David Alan Anthoney

St James's University Hospital

20

Papers

423

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

GLOBAL BALLAD: An International Rare Cancers Initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
FIESTA: A phase Ib and pharmacokinetic trial of AZD4547 in combination with gemcitabine and cisplatin.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (40)
ABC-03: A randomized phase II trial of cediranib (AZD2171) or placebo in combination with cisplatin/gemcitabine (CisGem) chemotherapy for patients (pts) with advanced biliary tract cancer (ABC).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A phase I trial of the ɣ-secretase inhibitor (GSI) MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma (PDAC).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Predictive factors for outcome after biliary stenting in malignant obstructive jaundice.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
6500 Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): final results of the UK ABC-02 trial

2009 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Severe Sequence-Specific Toxicity When Capecitabine Is Given After Fluorouracil and Leucovorin

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (18)
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

2006 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (13)
A phase II study of DJ-927 as second-line therapy in patients (pts) with advanced gastric cancer (GC) who have failed a 5-FU non taxane based regimen

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)